Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR Jr, Fountain KR, Benbrook DM.
Zacheis D, et al. Among authors: dhar a.
J Med Chem. 1999 Oct 21;42(21):4434-45. doi: 10.1021/jm990292i.
J Med Chem. 1999.
PMID: 10543887